Status:
COMPLETED
Comparing Two Different Ways to Take MoviPrep® Before Colonoscopy
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Bausch Health Americas, Inc.
Conditions:
Colonoscopy
Eligibility:
All Genders
18+ years
Brief Summary
This study will evaluate whether morning-only dosing of MoviPrep® (2L) for afternoon colonoscopy is as effective as a standard dosing regimen of half of the volume of MoviPrep® (1L) solution the eveni...
Detailed Description
primary objectives • To compare the efficacy of morning dose only MoviPrep® ("AM Dosing") where one-half of the prep is given 7 hours before colonoscopy and the second half is given 4 hours before co...
Eligibility Criteria
Inclusion
- Elective out-patients scheduled for afternoon colonoscopy (12 pm or later).
Exclusion
- Unable or unwilling to consent
- Age \< 18 years
- Pregnant
- Breast feeding
- Gastroparesis - known or suspected
- Chronic nausea or vomiting
- Bowel obstruction
- Hypomotility syndrome: pseudo-obstruction, megacolon, etc.
- Severe constipation (\< 1 BM a week)
- Greater than 50% resection of colon
- Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
- PEG allergy
- Significant psychiatric illness
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00929916
Start Date
December 1 2008
End Date
April 1 2009
Last Update
March 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107